A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy. The study was published on December 10, 2025, in Neurology, the medical journal of the American Academy of Neurology. Read more
Medical News - Dec 11
The FDA issued an “early alert” that some FreeStyle Libre 3 and FreeStyle Libre 3 Plus devices may provide incorrect low glucose readings. Read more
Wivb - Dec 05
Future versions of the noninvasive prototype may be as small as a watch.The post Goodbye, finger pricks? Diabetes patients could monitor glucose with lightwaves. appeared first on Popular Science. Read more
Popular Science - Dec 03
Certain glucose monitors from Abbott Diabetes Care are providing users with incorrect glucose readings, an error that has been linked with the deaths of at least seven people and more than 700 serious injuries worldwide, according to an alert from the US Food and Drug Administration. Read more
Cnn - Dec 02
Some FreeStyle Libre 3 glucose sensors made by Abbott Diabetes Care may give incorrect low readings. The devices have been linked to potential deaths. Read more
Usa Today - Dec 02
The enolase-1 inhibitor shows efficacy in a humanized mouse model of triple-negative breast cancer Read more
Chemical & Engineering News - Nov 14
Coherent Market Insights has added a new research study on the Global "Continuous Glucose Monitoring Market" 2025 by Size, Growth, Trends, and Dynamics, Forecast to 2032 which is a result of an extensive examination of the market patterns. This report Read more
Openpr.com - Nov 06
The global blood glucose test strips market size is estimated at USD 20.53 billion in 2025 and is projected to reach USD 35.54 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.10% during the forecast period Read more
Openpr.com - Nov 06
Adults with type 2 diabetes who consistently use continuous glucose monitor devices experience significantly greater blood sugar control than those who [...] Read more
University Of Washington - Nov 05
A fermented food that has been a staple on plates in Korea for thousands of years has gone global in the past decade, with new research revealing that kimchi can lower triglycerides and blood pressure and regulate fasting glucose levels.Continue ReadingCategory: Diet & Nutrition, Wellness and Hea... Read more
New Atlas - Sep 21
